-
-
-
-
-
-
-
Simulations Plus partners with NVIDIA for AI drug development workflows
-
-
-
-
-
-
-
Simulations Plus (SLP) Reiterated at Market Perform by Citizens
-
-
-
-
-
-
-
Simulations Plus reports preliminary fiscal 2025 revenue of $79.1 million
-
-
-
-
-
-
-
KeyBanc Downgrades Simulations Plus (SLP) to Sector Weight
-
-
-
-
-
-
-
Simulations Plus (SLP) Releases DILIsym 11
-
-
-
-
-
-
-
Oppenheimer Reiterates Outperform Rating on Simulations Plus (SLP)
-
-
-
-
-
-
-
Oppenheimer Reiterates Outperform Rating on Simulations Plus (SLP)
-
479,031 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


